Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Acarix AB (publ)

ACARIX.ST

HealthcareSTOSE

SEK 0.2625

+SEK 0.0085 (+3.35%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

ACARIX.ST

1Y+0.006 (+2.36%)

Candles, volume, SMA 20, and SMA 50

O 0.254H 0.267L 0.2535C 0.26Date Jun 10

ACARIX.ST

SMA 20 SMA 50 Vol 1.35M

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Acarix AB (publ) is a medical technology company that develops and introduces diagnostic solutions for cardiovascular conditions to markets including Germany, Sweden, the Middle East, Switzerland, Austria, and globally. Their key product is the CADScor System, an exceptionally sensitive, non-invasive analytical device designed for the detection of coronary artery disease. Founded in 2009, Acarix AB (publ) maintains its headquarters in Malmö, Sweden.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$294.87M

Volume?520.61K

Avg Volume?1.33M

52w RangeSEK 0.2245 - SEK 0.471

Beta?-0.21

Price Performance

No historical price data is available for this symbol yet.

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide